Thermo Fisher Scientific strives to create value for our customers. We are pleased to announce that in April, we will start working with a business partner in your research institution…
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the establishment of a new Center of Excellence (CoE) for…
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the introduction of the AccuLift™ Laser Capture Microdissection System. Ideal for translational…
GenapSys has completed a $90 million Series C financing round, with the proceeds set to fund commercialization of a namesake sequencer that according to the company will be the 100…
Spermatogenesis has been intensely studied in rodents but remains poorly understood in humans. Here, we used single-cell RNA sequencing to analyze human testes. Clustering analysis of neonatal testes reveals several…
Right now, most diseases are diagnosed after a patient develops symptoms, but a local company wants to change that. It's developed an ultra-sensitive blood protein test that company leaders hope…
Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a REAP-seq (RNA expression and protein sequencing) protocol for use with the C1™ system. C1…
The British company Horizon Discovery has obtained a license to develop a CRISPR-based gene editing tool from Rutgers University, USA, with potential applications in cancer and genetic disease.
Researchers with the Dominantly Inherited Alzheimer Network (DIAN) have found that serum neurofilament light chain (Nfl) levels could aid in diagnosing and monitoring the progression of Alzheimer's disease.
Horizon Discovery has introduced a new CRISPR screening service for use on primary human T cells, which will be valuable in researching biological processes and developing new drugs.